Klotho and FGF23: endocrine regulation of kidney disease outcomes

About the Article:

The Klotho–FGF23 axis plays a central role in regulating mineral metabolism through the intricate interaction between the kidneys, bones, and parathyroid glands. Disruption of this pathway is now recognised as a key driver in the progression of chronic kidney disease (CKD) and its systemic complications.

This review highlights how imbalance in this endocrine system contributes to:

✔️ Phosphate and vitamin D dysregulation

✔️ Vascular calcification and accelerated ageing processes

✔️ Renal fibrosis and progressive kidney damage

✔️ Increased cardiovascular risk

Importantly, the study also underscores the protective role of Klotho, which exhibits anti-inflammatory, antioxidant, and cytoprotective effects, positioning it as both a biomarker and a promising therapeutic target in kidney disease.

Why It Matters:

Emerging evidence suggests that restoring Klotho levels may offer reno-protective and cardio-protective benefits, opening new possibilities for early diagnosis and targeted treatment strategies in nephrology.

MORE PUBLICATIONS:
https://european-wellness.eu/publications/